LabCorp Introduces New ADAMTS13 Test for Rare Life-Threatening Blood Clot Disorder

LabCorp’s Proprietary Assay Offers Faster, More Accurate Diagnosis to Help Patients Receive Most-Appropriate Therapy BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 19, 2017-- LabCorp® (NYSE: LH) has begun offering its new, proprietary ADAMTS13 test to distinguish diseases characterized by

LabCorp’s William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 18, 2017-- LabCorp® (NYSE: LH), a leading global life sciences company, announced today that the National Evaluation System for health Technology Coordinating Center (NESTcc) has appointed William (Bill) Hanlon , Ph.D., chief development officer and head of

LabCorp and Novant Health Extend Laboratory Services Agreement

Extension Demonstrates Value of LabCorp’s Health System Collaborations BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 11, 2017-- LabCorp® (NYSE: LH) and Novant Health have agreed to a multi-year extension of their Technical Services Agreement, which was first implemented in 2012.

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 3, 2017-- LabCorp® (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject

Walgreens and LabCorp Collaborate to Bring Patient Service Centers for Laboratory Testing to Select Walgreens Stores

"LabCorp at Walgreens" Sites Will Provide Specimen Collection Services for LabCorp Testing Seven Service Centers Planned to Open at Walgreens Stores in 2017 DEERFIELD, Ill. & BURLINGTON, N.C.--( BUSINESS WIRE )--Walgreens and LabCorp® (NYSE: LH) today announced a collaboration through which

Covance Opens State-of-the-Art Laboratory for Companion Diagnostics

Dedicated Facility Furthers the Unmatched Value of the Combined Expertise of Covance Drug Development and LabCorp Diagnostics to Advance Precision Medicine BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 14, 2017-- LabCorp® (NYSE:LH), a leading global life sciences company, announced today that its

LabCorp Exclusively Launches Sera Prognostics’ PreTRM Test to Assess for Risk of Preterm Birth

The PreTRM Test is the Only Validated Test That Provides Early and Individualized Evaluation of Preterm Birth Risk BURLINGTON, N.C. --(BUSINESS WIRE)--May 23, 2017-- LabCorp® (NYSE: LH) today announced the nationwide availability of the PreTRM® test. Developed by Sera Prognostics, Inc.

LabCorp is Scheduled to Present at the Bank of America Merrill Lynch 2017 Health Care Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--May 9, 2017-- LabCorp® (NYSE: LH) today announced it will participate at the Bank of America Merrill Lynch 2017 Health Care Conference . LabCorp’s presentation is scheduled for Tuesday, May 16, 2017 , at 10:40 a.m. PT .

LabCorp Completes Acquisition of Pathology Associates Medical Laboratories

Transaction Establishes Relationships with Community-Based Health Systems Across Multiple States BURLINGTON, N.C. & RENTON, Wash. & ENGLEWOOD, Colo.--( BUSINESS WIRE )--LabCorp® (NYSE:LH) has completed the acquisition of Pathology Associates Medical Laboratories (PAML) from former owners

LabCorp to Webcast Its Annual Meeting of Shareholders

BURLINGTON, N.C. --(BUSINESS WIRE)--May 4, 2017-- LabCorp® (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 11, 2017 at 9:00 a.m. Eastern Daylight Time via the Company website at www.labcorp.com . An archived replay of the audio webcast will be